D. Pascual and A. Borque, Epidemiology of Kidney Cancer, Advances in Urology, vol.6, issue.4, p.782381, 2008.
DOI : 10.1016/S0002-9343(02)01049-5

J. Ferlay, P. Autier, M. Boniol, M. Heanue, and M. Colombet, Estimates of the cancer incidence and mortality in Europe in 2006, Annals of Oncology, vol.18, issue.3, pp.581-592, 2006.
DOI : 10.1093/annonc/mdl498

H. Cohen and F. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-2490, 2005.
DOI : 10.1056/NEJMra043172

B. Rini, S. Campbell, and B. Escudier, Renal cell carcinoma, The Lancet, vol.373, issue.9669, pp.1119-1132, 2009.
DOI : 10.1016/S0140-6736(09)60229-4

A. Lopez-beltran, J. Carrasco, L. Cheng, M. Scarpelli, and Z. Kirkali, 2009 update on the classification of renal epithelial tumors in adults, International Journal of Urology, vol.32, issue.2, pp.432-443, 2009.
DOI : 10.1111/j.1442-2042.2009.02302.x

M. Nickerson, E. Jaeger, Y. Shi, J. Durocher, and S. Mahurkar, Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors, Clinical Cancer Research, vol.14, issue.15, pp.4726-4734, 2008.
DOI : 10.1158/1078-0432.CCR-07-4921

M. Nyhan, O. Sullivan, G. Mckenna, and S. , (von Hippel???Lindau) gene in renal cancer: a multifunctional tumour suppressor, Biochemical Society Transactions, vol.36, issue.3, pp.472-478, 2008.
DOI : 10.1042/BST0360472

W. Kaelin, von Hippel-Lindau Disease, Annual Review of Pathology: Mechanisms of Disease, vol.2, issue.1, pp.145-173, 2007.
DOI : 10.1146/annurev.pathol.2.010506.092049

W. Kaelin and J. , The von Hippel???Lindau tumour suppressor protein: O2 sensing and cancer, Nature Reviews Cancer, vol.60, issue.11, pp.865-873, 2008.
DOI : 10.1016/S1535-6108(02)00042-9

A. Osunkoya, Q. Yin-goen, J. Phan, R. Moffitt, and T. Stokes, Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis, Human Pathology, vol.40, issue.12, 2009.
DOI : 10.1016/j.humpath.2009.05.006

J. Ortiz-rey, C. Gomez-de-maria, P. Boismorand, E. , F. Costas et al., Expresi??n de CD10 y del marcador de carcinoma renal en el carcinoma renal de c??lulas claras: An??lisis en matrices tisulares, Actas Urol??gicas Espa??olas, vol.30, issue.3, pp.281-286, 2006.
DOI : 10.1016/S0210-4806(06)73440-4

R. Gupta, B. Balzer, M. Picken, A. Osunkoya, and T. Shet, Diagnostic Implications of Transcription Factor Pax 2 Protein and Transmembrane Enzyme Complex Carbonic Anhydrase IX Immunoreactivity in Adult Renal Epithelial Neoplasms, The American Journal of Surgical Pathology, vol.33, issue.2, pp.241-247, 2009.
DOI : 10.1097/PAS.0b013e318181b828

C. Pan, P. Chen, and D. Ho, The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases, Histopathology, vol.49, issue.5, pp.452-459, 2004.
DOI : 10.1046/j.1440-1827.2000.01070.x

B. Skinnider and M. Amin, An immunohistochemical approach to the differential diagnosis of renal tumors, Seminars in Diagnostic Pathology, vol.22, issue.1, pp.51-68, 2005.
DOI : 10.1053/j.semdp.2005.11.004

Y. Allory, C. Bazille, A. Vieillefond, V. Molinie, and B. Cochand-priollet, Profiling and classification tree applied to renal epithelial tumours, Histopathology, vol.29, issue.0, pp.158-166, 2008.
DOI : 10.1038/modpathol.3800236

A. Galaup, A. Cazes, L. Jan, S. , P. J. Connault et al., Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness, Proceedings of the National Academy of Sciences, vol.103, issue.49, pp.18721-18726, 2006.
DOI : 10.1073/pnas.0609025103
URL : https://hal.archives-ouvertes.fr/inserm-00132128

C. Chomel, A. Cazes, C. Faye, M. Bignon, and E. Gomez, Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity, The FASEB Journal, vol.23, issue.3, pp.940-949, 2009.
DOI : 10.1096/fj.08-115170
URL : https://hal.archives-ouvertes.fr/inserm-00341205

M. Yau, Y. Wang, K. Lam, J. Zhang, and D. Wu, A Highly Conserved Motif within the NH2-terminal Coiled-coil Domain of Angiopoietin-like Protein 4 Confers Its Inhibitory Effects on Lipoprotein Lipase by Disrupting the Enzyme Dimerization, Journal of Biological Chemistry, vol.284, issue.18, pp.11942-11952, 2009.
DOI : 10.1074/jbc.M809802200

D. Padua, X. Zhang, Q. Wang, C. Nadal, and W. Gerald, TGF?? Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4, Cell, vol.133, issue.1, pp.66-77, 2008.
DOI : 10.1016/j.cell.2008.01.046
URL : http://doi.org/10.1016/j.cell.2008.01.046

L. Jan, S. Amy, C. Cazes, A. Monnot, C. Lamande et al., Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma, The American Journal of Pathology, vol.162, issue.5, pp.1521-1528, 2003.
DOI : 10.1016/S0002-9440(10)64285-X

S. Fuhrman, L. Lasky, and C. Limas, Prognostic significance of morphologic parameters in renal cell carcinoma, The American Journal of Surgical Pathology, vol.6, issue.7, pp.655-663, 1982.
DOI : 10.1097/00000478-198210000-00007

V. Ficarra, A. Galfano, M. Mancini, G. Martignoni, and W. Artibani, TNM staging system for renal-cell carcinoma: current status and future perspectives, The Lancet Oncology, vol.8, issue.6, pp.554-558, 2007.
DOI : 10.1016/S1470-2045(07)70173-0

N. Weinbreck, M. B. Bressenot, A. Montagne, K. Joud, and A. , Immunohistochemical Markers to Distinguish Between Hemangioblastoma and Metastatic Clear-cell Renal Cell Carcinoma in the Brain: Utility of Aquaporin1 Combined With Cytokeratin AE1/AE3 Immunostaining, The American Journal of Surgical Pathology, vol.32, issue.7, pp.1051-1059, 2008.
DOI : 10.1097/PAS.0b013e3181609d7d

M. Perigny, P. Hammel, O. Corcos, O. Larochelle, and S. Giraud, Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression, Am J Surg Pathol, vol.33, pp.739-748, 2009.

F. Van-nederveen, J. Gaal, J. Favier, E. Korpershoek, and R. Oldenburg, An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, The Lancet Oncology, vol.10, issue.8, pp.764-771, 2009.
DOI : 10.1016/S1470-2045(09)70164-0

N. Gokden, M. Gokden, D. Phan, and J. Mckenney, The Utility of PAX-2 in Distinguishing Metastatic Clear Cell Renal Cell Carcinoma From its Morphologic Mimics, The American Journal of Surgical Pathology, vol.32, issue.10, pp.1462-1467, 2008.
DOI : 10.1097/PAS.0b013e318176dba7

Z. Hu, C. Fan, C. Livasy, X. He, and D. Oh, A compact VEGF signature associated with distant metastases and poor outcomes, BMC Medicine, vol.68, issue.4, p.9, 2009.
DOI : 10.1158/0008-5472.CAN-07-2017

M. Takahashi, D. Rhodes, K. Furge, H. Kanayama, and S. Kagawa, Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification, Proceedings of the National Academy of Sciences, vol.98, issue.17, pp.9754-9759, 2001.
DOI : 10.1073/pnas.171209998

B. Lane, J. Li, M. Zhou, D. Babineau, and P. Faber, Differential Expression in Clear Cell Renal Cell Carcinoma Identified by Gene Expression Profiling, The Journal of Urology, vol.181, issue.2, pp.849-860, 2009.
DOI : 10.1016/j.juro.2008.10.069

H. Zhao, B. Ljungberg, K. Grankvist, T. Rasmuson, and R. Tibshirani, Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma, PLoS Medicine, vol.351, issue.1, p.13, 2006.
DOI : 10.1371/journal.pmed.0030013.st001

D. Wuttig, B. Baier, S. Fuessel, M. Meinhardt, and A. Herr, Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient, International Journal of Cancer, vol.107, issue.2, pp.474-482, 2009.
DOI : 10.1002/ijc.24353

J. Gnarra, K. Tory, Y. Weng, L. Schmidt, and M. Wei, Mutations of the VHL tumour suppressor gene in renal carcinoma, Nature Genetics, vol.88, issue.1, pp.85-90, 1994.
DOI : 10.1038/ng0594-85

P. Schraml, K. Struckmann, F. Hatz, S. Sonnet, and C. Kully, VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma, The Journal of Pathology, vol.87, issue.2, pp.186-193, 2002.
DOI : 10.1002/path.1034